Connor, Clark & Lunn Investment Management (CC&L)’s Precision BioSciences DTIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,852
| Closed | -$102K | – | 1300 |
|
|
2022
Q4 | $102K | Sell |
2,852
-1,041
| -27% | -$37.2K | ﹤0.01% | 1108 |
|
|
2022
Q3 | $152K | Buy |
3,893
+488
| +14% | +$19.1K | ﹤0.01% | 1019 |
|
|
2022
Q2 | $163K | Buy |
3,405
+3,017
| +778% | +$144K | ﹤0.01% | 955 |
|
|
2022
Q1 | $36K | Buy |
388
+13
| +3% | +$1.21K | ﹤0.01% | 1007 |
|
|
2021
Q4 | $83K | Sell |
375
-8
| -2% | -$1.77K | ﹤0.01% | 1037 |
|
|
2021
Q3 | $133K | Buy |
+383
| New | +$133K | ﹤0.01% | 968 |
|